Serum's partner Novavax gets first emergency use authorization for its Covid vaccine
- The vaccine will be manufactured by India's Serum Institute and marketed by SII in Indonesia under the brand name COVOVAX
Novavax and Serum Institute of India on Monday announced that their Covid vaccine has got emergency use authorization from Indonesia. The National Agency of Drug and Food Control of the Republic of Indonesia has granted emergency use authorization (EUA) for Novavax' recombinant nanoparticle protein-based Covid vaccine, Novavax said in a statement.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more